April Bio: Funding, Investors & Team (Oct 2026)
April Bio is a drug development company that develops antibodies and long-acting biologics.
April Bio has raised $124M across 1 funding round on record, the most recent an undisclosed round of $124M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
April Bio Company Profile and Key Stats
Latest funding round on record: Jun 2026.
April Bio Funding Rounds
April Bio Founders and Leadership Team
No contact details are on record for this team yet.
April Bio Funding Compared to Other Biotechnology Startups
April Bio's latest round of $124M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like April Bio in Biotechnology and Chuncheon
Companies Similar to April Bio
ArcGen Bioscience is a biopharmaceutical development company
Lego Chem Bioscience , a company created by people with dreams and enthusiasm for global new drug…
The company is a spin-off from Asan Medical Center, University of Ulsan University, with a primary objective…
LabGenomics is a healthcare company specialized in molecular diagnostics.
Galaxy operates a pharmaceutical research and development company for the treatment of encephalopathy and…
SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique…
3billion was founded with the goal of ending the diagnostic odyssey of rare disease patients through…
Shaperon is a clinical-stage biotech company that develops inflammasome inhibitors.
SN BioScience provide nano-formulation screening services for small molecule, oligonucleotide (siRNA, DNA),…
M-Based develops new alternative material technologies using mushrooms. 🍄 We consider environmental…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
April Bio Funding FAQs
What does April Bio do?
April Bio is a drug development company that develops antibodies and long-acting biologics.
How much funding has April Bio raised?
April Bio has raised $124M across 1 round on record. The most recent is an undisclosed round of $124M announced in Jun 2026.
When did April Bio last raise funding?
April Bio's most recent funding round on record is an undisclosed round of $124M, announced in Jun 2026.
Who founded April Bio?
FundedIQ lists April Donovan (Founder) at April Bio.
Where is April Bio headquartered?
April Bio is based in Chuncheon, Kangwon-do, South Korea.
How many employees does April Bio have?
April Bio is in the 11-50 employee band.
How does April Bio's funding compare to other Biotechnology startups?
April Bio's latest round of $124M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's April Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for April Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.